Anti-Sp4 and anti-CCAR1 autoantibodies in UK <i>vs</i> US patients with adult and juvenile-onset anti-TIF1γ-positive myositis

Anti-Sp4 and anti-CCAR1 autoantibodies are less common in the adult UK anti-TIF1γ-positive myositis population compared with published data from the USA, limiting their use as biomarkers for cancer risk. In patients with juvenile onset disease, anti-Sp4 is less frequent in UK patients compared with the USA, but the prevalence of anti-CCAR1 autoantibodies is similar.

Authors

Institutions

Publication Details

Journal
Lara D. Veeken
Published
2024-11-07
DOI
https://doi.org/10.1093/rheumatology/keae574
Citations
2
Primary Topic
Inflammatory Myopathies and Dermatomyositis
Type
article
Field-Weighted Citation Impact
0.77

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Anti-Sp4 and anti-CCAR1 autoantibodies in UK vs US patients with adult and juvenile-onset anti-TIF1γ-positive myositis

Claire T. Deakin, Verna Cuthbert, Muthana Al-Obadi, Livia Casciola‐Rosen et al.
2 citations
Lara D. Veeken
Inflammatory Myopathies and Dermatomyositis
0.77
article

Anti-Sp4 and anti-CCAR1 autoantibodies in UK vs US patients with adult and juvenile-onset anti-TIF1γ-positive myositis

Claire T. Deakin, Verna Cuthbert, Muthana Al-Obadi, Livia Casciola‐Rosen, Elizabeth Stretton, Amy Huffenberger, Lee S. Nguyen, Heather Chisem, Hemlata Varsani, Audrey Juggins, Manija Asif, Kiran Nistala, Eileen Baildam, Linda Suffield, Jane Roach, Anna Fry, V. Stevenson, Louise Turner, Fionnuala K McMorrow, Julie Cook, Phil Riley, Michael Browne, Raquel Marques, Neil A. Martin, Chia-Ping Chou, Emily Robinson, Clarissa Pilkington, Charalampia Papadopoulou, Adaani Frost, Jeanette Hall, Lauren E. Stone, Meredyth Wilkinson, Polly Livermore, Lorena Caruana, Laura Kassoumeri, Steven D. Leach, Parichat Khaosut, Alexander Oldroyd, Emily Blyth, Virginia Brown, T. R. E. Southwood, J Ioannou, Andrew Lee Mammen, Helen Foster, Lucy R. Wedderburn, Liz Waxman, Heather Rostron, Ruth Etherton, Lisa G. Rider, Laura Hennelly, Giulia Varnier, Ruth Howman, Eve Smith, Yvonne Glackin, Hans de Graaf, Sarah Hanson, Christopher Piper, E. J. MacLeod, Margaret Connon, Mary Jordan, Ethan S Sen, Stephen Crulley, Stefanie Stafford, Vanessa VanRooyen, Danielle Miller, Kathryn Bailey, Mark Wood, Kirsty Haslam, Miss Caroline Miller, Kevin Murray, Socrates Varakliotis, Lynne Bell, Hector Chinoy, Katie Arnold, Sandrine Lacassagne, Louise Akeroyd, Louise Hanna, Neil McHugh, Stefanie Dowle, Stephanie Simou, Roisin Boyle, Caitlin Clifford, Sue A. Ferguson, Mary A. Beard, Helen Smith, Dario Cancemi, Janine A. Lamb, Rosie Hamilton, Rebecca Cutts, Sarah Tansley, Coziana Ciurtin, H Venning, Liza McCann, Claire Duong, Lindsay Crate, Stuart Watson, Melanie Marsh, E. J. C. Kendall, Olivia Lloyd, Alice Leahy, Natalie Fineman, Flora McErlane, Ellen Mosley, Sue Maillard, Sian Lunt, Helen Pluess-Hall, Liang Qiao, Helen Lee, Lucy Marshall, Ann McGovern, Satyapal Rangaraj, Ian Roberts, Clive Ryder, Christina Boros, Brian Davidson, Kate Armon, Michelle Andrews, Amy Collier, Susanne Cathcart, Beverley Thomas, Andrew J. Davies, Mark Friswell, Nathan Hasson, Anne-Marie McMahon, Andrew C. Swift, Sue Wyatt, Eslam Al-Abadi, Gillian Jackson, Josh Bennet, Louise Coke, Jacqui Clinch, Janet Gardner‐Medwin, Trudy Booth, Douglas L. Mayers, Debbie Wade, Sunil Sampath, Tania Amin, Sharmila Jandial, Sally A. Smith, Nick Wilkinson, Beverley Almeida, J Scott, Deborah Burton, Kishore Warrier, Shireena A. Yasin, Kathryn O’Brien, Amy Nichols, Cerise Johnson-Moore, Dominic Igbelina, Emma Inness, Suzanne Sketchley, Maisy Dawkins-Lloyd, Lindsay Vallance, Charlene Bass-Woodcock, Sarah Hartfree, Elizabeth Fofana, Susan Wadeson, Brogan Wrest, Elizabeth Halkon, Elli Enayat, Paul Pryce, Sharon King
article en
2 citations

Abstract

Anti-Sp4 and anti-CCAR1 autoantibodies are less common in the adult UK anti-TIF1γ-positive myositis population compared with published data from the USA, limiting their use as biomarkers for cancer risk. In patients with juvenile onset disease, anti-Sp4 is less frequent in UK patients compared with the USA, but the prevalence of anti-CCAR1 autoantibodies is similar.

Lara D. VeekenVol. 64(6)
Royal National Hospital for Rheumatic Diseases (GB), National Institutes of Health (US), Johns Hopkins University (US), Manchester Academic Health Science Centre (GB), Johns Hopkins Medicine (US), Great Ormond Street Hospital (GB), University of Manchester (GB), National Institute of Arthritis and Musculoskeletal and Skin Diseases (US), National Institute of Environmental Health Sciences (US), National Institute of Nursing Research (US), Salford Royal Hospital (GB), Arthritis UK (GB), Institute of Child Health (IN), University College London (GB), University of Bath (GB)
Wellcome Trust, University Hospital Southampton NHS Foundation Trust, Myositis Association, Action Medical Research, National Institute for Health and Care Research, Department of Health and Social Care, University College London, University of Oxford, Deakin University, Hospital for Sick Children, Versus Arthritis, National Institutes of Health, Manchester Biomedical Research Centre, Medical Research Council
Openalex Percentile: Top 24%
Inflammatory Myopathies and Dermatomyositis
0.77
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.